# 68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma

> **NCT01801371** · EARLY_PHASE1 · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DRUG:** 68Ga-BNOTA-PRGD2

## Key facts

- **NCT ID:** NCT01801371
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01801371

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01801371, "68Ga-BNOTA-PRGD2 PET/CT in Diagnosis and Evaluation of Glioma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01801371. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*